Antisense Therapeutics
Melbourne
About Antisense Therapeutics
Antisense Therapeutics is a biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $7.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2020)
- Ticker: asx:ANP
- Website: antisense.com.au
- Phone: +61 (3) 9827 8999
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/antisense-therapeutics-2233810 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.